Background The major morbidity of percutaneous transluminal coronary angioplasty is acute thrombosis and restenosis of the dilated lesion. Platelet-thrombus deposition occurs within minutes after injury, is primarily mediated by thrombin, causes acute occlusion, and contributes to late restenosis. Experimentally, specific thrombin inhibitors have prevented mural thrombosis. However, local therapy may be more effective than systemic treatment. We tested the hypothesis that high local concentrations of an antithrombin drug at the site of arterial injury following balloon angioplasty inhibit platelet thrombus formation equally or better than conventional systemic treatment and at lower systemic anticoagulant levels.
Methods and Results Balloon angioplasty of the carotid arteries of 29 pigs was performed using systemic intravenous treatment with heparin (100 U/kg, groups I and II), suboptimal r-hirudin (0.3 mg/kg, group III), and higher-dose r-hirudin (0.7 mg/kg, group IV), which is the lowest dose that completely inhibited arterial thrombosis in the pig. Immediately after balloon angioplasty of the first carotid, additional local therapy with placebo (group I) or r-hirudin (groups II, III, and IV; 0.3 mg/kg in 1 mL) was administered with distal perfusion through a new percutaneous double-balloon catheter. After 1 hour of local drug delivery, angioplasty of the contralateral carotid was performed. Reflow for 1 hour was permitted to S equelae of coronary balloon angioplasty are acute thrombosis in 3% to 12% of patients and restenosis in 25% to 40% of patients.1,2 Balloon angioplasty disrupts the arterial wall with injury into the atherosclerotic plaque or media that releases tissue thromboplastin (tissue factor) and exposes highly thrombogenic deep arterial structures (smooth muscle cells [SMC] , collagen types I and III) to flowing blood. 3 Deep arterial injury activates the coagulation system with generation of large amounts of thrombin via the formation of the prothrombinase complex (factors II, In-labeled platelet deposition and macroscopic mural thrombus formation on deeply injured carotid segments. Local drug delivery of placebo compared with systemic heparin treatment resulted in no change of platelet deposition (x 106/ cm , mean+SEM) in controls (group I, 91.0±23.5 versus 80.8±19.4), but local delivery of r-hirudin resulted in a significant reduction in group 11 (15+2.5 versus 71.3+14.5; P<.02) and group III (11.4±2.5 versus 80.5+11.4; P<.01) and was borderline in group IV (7.4±1.8 versus 14.1±7.4; P=.05), respectively. The incidence of macroscopic mural thrombus formation with local and systemic treatment was 86% and 75% in group I, 16% and 70% in group II, 14% and 71% in group III, and 0% and 16% in group IV, respectively.
Conclusions Local therapy with the specific thrombin inhibitor r-hirudin significantly reduces short-term quantitative platelet deposition and macroscopic mural thrombus formation following balloon angioplasty compared with systemic treatment of conventional doses of heparin and hirudin and requires a significantly smaller amount of the recombinant drug. (Circulation. 1994; 90:2474 -2480 Key Words * angioplasty * r-hirudin * thrombosiscatheters * platelets Va, and Xa; Ca2`-all assembled on a phospholipid membrane such as platelets or SMC). Thrombin is a potent stimulus for platelet activation and results in a positive feedback for activation of factors V and VIII, conversion of fibrinogen to fibrin, and cross-linking of fibrin by activation of factor XIII.4 Heparin is a coenzyme of circulating antithrombin III (ATIII) and greatly accelerates the interaction of ATIII with thrombin but at the conventional dose does not completely prevent mural thrombus formation.5 Specific inhibition of thrombin in vivo eliminates macroscopic mural thrombus formation and limits platelet deposition to a single layer or less. 6 Thrombin also contributes to SMC proliferation by stimulating platelet secretion of growth factors (especially platelet-derived growth factor [PDGF] ) and directly acting on SMC. Thus, specific thrombin inhibition may be important for preventing restenosis. 7 Failure of conventional pharmacological therapies8 to prevent thrombus and restenosis following coronary angioplasty in patients has led to the evaluation of local 
Drug Delivery System
The drug delivery system used in the study was a doubleballoon perfusion catheter (Cordis). The catheter has a 4.5F quadruple-lumen shaft with two distal balloons made of polyethylene tetraphalate with separate inflation lumens. The balloons were 5 mm in diameter, 10 mm long, and 43 mm apart. r-Hirudin was locally administered through a central instillation port to the injury site within the protected space created by the two balloons. During balloon inflation, autoperfusion of the distal artery occurred via the fourth lumen with proximal side holes in the catheter shaft at a perfusion flow rate of 55 mL/min (in vitro studies, conducted with a glycerol solution at 37°C and a proximal perfusion pressure of 80 mm Hg).
All procedures performed in this study conformed to the National Institutes of Health and American Heart Association guidelines for animal research and were approved by the Massachusetts General Hospital Animal Care Committee.
Experimental Procedures
The animals were sedated with ketamine (20 mg/kg Ketalar; Parke-Davis) and atropine (0.6 mg/kg) administered in combination by intramuscular injection. An intravenous line was established, and each animal received intravenous sodium pentobarbital (10 mg/kg Injection C, Anpro Pharmaceutical).
The pigs were intubated and mechanically ventilated with a volume ventilator (Searle). The ECG and intra-arterial blood pressure were continuously monitored throughout the procedure. Both femoral arteries were catheterized with 8F introducer sheaths. After a bolus of heparin or hirudin, the infusions were administered through the left mammary vein delivered with a Harvard pump (Harvard Apparatus) at a rate of 10 mL/h. Heparin used in this study was heparin sodium derived from porcine intestine that contained 1000 USP U/mL (Elkins-Sinn). The r-hirudin was recombinant desulfatohirudin from yeast (CGP 39393, CIBA-GEIGY).
Carotid Angioplasty and Local Drug Delivery of r-Hirudin
The model of carotid arterial injury has been previously described.5,6,14 A SF Cordis polyethylene balloon angioplasty catheter (8 x 20 mm) was advanced via the left femoral artery under fluoroscopic guidance into the common carotid artery and placed 6 cm distal to the bifurcation by a radiopaque ruler attached to the skin (between cervical vertebrae 1 and 3). The common carotid arterial segments were dilated by five 30-second inflations to 6 to 8 atm with 60-second intervals between inflations. After the final inflation, the angioplasty equipment was removed, and the double-balloon device was positioned through an 8F multipurpose guiding catheter between radiopaque markers to cover the injured carotid segment. The proximal balloon was inflated to a pressure of 1 to 3 atm for complete occlusion. Autoperfusion was checked by contrast injections through the guiding catheter. The carotid artery distal to the occlusive balloon was flushed with saline 0.9% via instillation port of the dual-balloon catheter, and the distal balloon was inflated to occlusion (1 to 3 atm). Then, placebo (group I) or 0.3 mg/kg r-hirudin in 1 mL (groups II, III, and IV) was administered into the compartment for 1 hour. Balloon occlusion was repeatedly checked with contrast injections (diatrizoate meglumine and diatrizoate sodium; Angiovist, Berlex Laboratory Inc), and spot films and video recordings were taken during balloon inflations. Pressure calibration and monitoring were performed using two digital pressure manometers (Indeflator, ACS). The autoperfusion lumen was flushed every 5 minutes with 1 mL of 0.9% saline containing 50 U heparin/mL. After 1 hour of local drug delivery with the balloon, angioplasty of the contralateral carotid artery was performed via the right femoral artery as described above. After the final inflation, the angioplasty catheter and the double-balloon perfusion catheter were removed, and local r-hirudin was released systemically. Pigs were killed after 1 hour of perfusion to measure quantitativè
In-labeled platelet deposition as well as to evaluate the depth of injury and macroscopic mural thrombus formation.
Postmortem Procedures
Fifty milliliters of 0.5% Evans blue dye in 0.9% saline was injected into a femoral artery 15 minutes before death. The pigs were given an overdose of pentobarbital and perfused antegradely with 0.01 mol/L phosphate-buffered saline (PBS) followed by 4% paraformaldehyde in PBS into the aorta at a pressure of 100 mm Hg for 15 minutes to allow fixation of the arteries in situ. The carotids were dissected and cleaned of all periadventitial tissue. The dilated portion of the injured carotid arteries, and the segments representing the location of the occlusive balloons were easily identified by Evans blue staining and by measurements taken during fluoroscopy and at autopsy with the carotid bifurcation as the point of reference. The dilated portion of the fixed carotid artery was divided into three 10-mm segments. From the adjacent ends, two proximal and distal segments of similar size were taken, representing the area of the occlusive balloons and proximal and distal controls, respectively. All deep arterial injury was confined to the three segments in the dilated region except for two arteries where a tear extended proximally; in these animals an extra segment was analyzed. Segments were not analyzable if there was a mechanical problem, ie, rupture of the carotid artery during angioplasty resulting in a large perivascular hematoma, or if there was a leak of one of the balloons of the local delivery catheter.
Degree of Injury and Mural Thrombus
After isotope counting, each segment was cut open with a dissecting scissors and examined for the presence of macroscopic mural thrombus using a 2x magnifier. 15 Then, all segments were processed for histology to evaluate the degree of vessel wall injury. From each arterial segment, three cross sections were stained with hematoxylin and eosin and Masson's trichrome stain. Light microscopy by two observers (B.J.M., A.F.O.) documented the presence of a tear or a dissection into the media at the site of injury and the absence of an injury at the site of the occlusive balloons. A tear extending through the internal elastic lamina into the media was defined as severe/deep injury; endothelial denudation (identified by Evans blue staining) without a tear through the internal elastic lamina was considered mild subendothelial injury.
Quantitation of Platelet Deposition
Platelet deposition on the arterial segments was quantitated as previously described.> 6 Three blood samples were obtained at the time of death for determination of mean blood radioactivity in counts per minute (cpm) normalized by the weight of the collected blood (microbalance) and corrected for unbound 111In. Radioactivity in each arterial segment and in blood was measured in a gamma well counter (Packard Auto-Gamma 5650) with the spectrometer adjusted to include the photo peaks at 174, 247, and 421 keV (sum peak) of the 1In radionuclide. The number of platelets deposited on each segment was calculated from the 11.In activity of the segment, the specific 1`In activity in whole blood, and the platelet count of whole blood with the method previously described. 6 
Laboratory Tests
Blood was drawn from the femoral artery to determine basal platelet count, hematocrit, aPTT, fibrinogen, and heparin levels. Similar testing was performed in samples taken 10 minutes after starting the infusion of heparin and hirudin, just before and after carotid angioplasty, during and after local delivery, and immediately before death (Fig 1) . Platelet count and hematocrit were measured with a cell counter (System 9000, Serono-Baker Diagnostics). Blood for aPTT and heparin levels was mixed 9:1 with a 3.2% trisodium citrate solution and then centrifuged to obtain platelet-poor plasma. aPTT levels were determined using a standard technique (ST4, American Bioproducts Co). Within 4 hours of blood collection, heparin levels were determined according to the level of anti-factor Xa activity using a commercially available kit (Hepaclot, American Bioproducts Co). Fibrinogen concentration was determined after an excess of thrombin was added by measuring the clotting time (Fibri-Prest, American Bioproducts Co).
Statistical Analysis
Because of the large differences in platelet deposition between deep and subendothelial injuries, separate analysis was performed for these two types of injury. All values were recorded as the mean+SEM value unless otherwise stated.
Comparisons of the extent of platelet deposition were performed by using the Mann-Whitney U and Kruskal-Wallis tests. Pearson's x2 was used to test for differences within groups in the incidence of mural thrombus. Mean values of aPTT, aPTT ratio, hematocrit, plasma fibrinogen, and platelets before and during the procedure were compared between groups.
Results

Study Design
The number of pigs and the segments with deep and subendothelial injury in each group are shown in the Table. Separate analysis was performed for these two types of injury because of the large differences in platelet deposition between deep and subendothelial injuries, as previously reported.6 '16 Four animals with rupture and total occlusion after angioplasty of the carotid artery were excluded from the analysis as well as two animals with a defective local drug delivery device, ie, proximal balloon leak as documented by loss of pressure of the manometer and by angiographic contrast filling of the local delivery compartment.
In Platelet Deposition
When the number of platelets was adjusted for the area of deep injury, platelet deposition was not different in animals treated with local delivery of saline (controls) compared with systemic treatment with 100 U/kg heparin (Fig 2A) . Platelet deposition in animals treated with locally administered r-hirudin (0.3 mg/kg in 1 mL) was significantly lower than in those with systemic treatment by 100 U/kg heparin (group II) and 0.3 mg/kg r-hirudin (group III) alone. Platelet during balloon angioplasty and no additional deep injury due to the double balloon. As Fig 4 shows , no difference in mean platelet deposition was found in the carotid segments adjacent to the balloon angioplasty area, representing the location of the two balloons and the control segments of the contralateral carotid artery.
Laboratory Data
Mean aPTT levels and ratios during systemic heparin and r-hirudin infusion as well as during local drug U 1 . administration are shown in Fig 5. The aPTT levels were achieved 10 minutes after starting the heparin and r-hirudin infusions and remained stable throughout the precedure. The mean aPTT level in the 0.3 mg/kg r-hirudin-treated group was significantly lower than in the 0.7 mg/kg r-hirudin-and 100 U/kg heparin-treated groups, as was the average aPTT ratio (1.7±0.1, 2.4±0.1, 2.6±0.1, and 2.4±0.1 [control], respectively).
There was no difference in platelet count, hematocrit, and fibrinogen levels regardless of the drug dosage, and the levels remained stable throughout the experiments.
Discussion
This study of deep arterial injury demonstrates that adjunctive local administration of highly concentrated r-hirudin reduces platelet deposition and macroscopic mural thrombus formation compared with systemic antithrombotic therapy. Local delivery of r-hirudin is more effective than a conventional dose of heparin (aPTT ratio >2) or a dose of hirudin (aPTT ratio 1.7) currently used in clinical trials. Adjunctive locally delivered r-hirudin appears to be better than the higher dose of systemic hirudin used in this study (aPTT ratio .2.0), which was previously effective in preventing mural thrombosis.6 Simple exclusion of blood from the site of arterial injury and local administration of saline had no effect on acute platelet deposition (Fig 2A) .
The percutaneous transluminal double-balloon catheter with an autoperfusion lumen used in this study is a feasible device for local drug administration for a duration of 1 hour. When compared with the contralateral artery, this device causes no additional vessel wall damage as assessed by light microscopic examination of the arterial segments at the site of the balloon inflation.
If flushed regularly, the perfusion device at a flow rate of 55 mL/min remained patent and caused no arterial wall thrombus at all levels of anticoagulation used in the three groups for 1 hour.
Arterial injury triggers activation of the coagulation system and platelets that, together with the arterial wall matrix, generate large amounts of thrombin within minutes by the prothrombinase complex.17'8 Thrombin binds to SMCs, arterial wall matrix, and platelet membrane receptors and produces platelet activation and subsequent arterial thrombosis. 4, 19 Mild arterial injury (endothelial denudation) without associated stenosis results in a single layer of platelet deposition. After deep injury below the internal elastic membrane, mural thrombosis is present in 80% to 90% of segments with marked platelet deposition.6 More thrombin appears to be present after deep than after mild arterial injury. 20 Although both heparin and hirudin are antithrombin drugs, their interactions with thrombin and efficacy in arterial thrombosis are very different. 5, 6 Hirudin is active against clot-bound thrombin, whereas fibrin bound to thrombin masks receptors to ATIII and heparin cofactor II and prevents significant inhibition of clot-bound thrombin.21,22 Moreover, hirudin and other low-molecular thrombin inhibitors such as PPACK,23 argatroban,24 and Hirulog25 are effective inhibitors of thrombin-induced platelet activation following arterial injury, whereas heparin is not. There are three possible effects that may have contributed to the marked antithrombotic potency of specific thrombin inhibition with locally delivered r-hirudin compared with conventional systemic dosing. (1) The higher efficacy of local antithrombin may relate to the high local concentration of r-hirudin and the prolonged surface interaction of 1 hour. Local concentration of r-hirudin, which is 1500-to 3000-fold higher at the injury site than systemic levels achieved during continuous infusion, may diffuse into the arterial wall and induce faster and more efficient inhibition of surface and intramural thrombin compared with systemic heparin or low-dose r-hirudin. (2) Clotbound thrombin2' and extracellular matrix-bound thrombin26 are protected from inhibition by heparin-ATIII. However, r-hirudin can inactivate thrombin bound to the arterial wall matrix and fibrin. High local concentration of r-hirudin may penetrate mural thrombus and the arterial wall more rapidly and deactivate the thrombogenic surface more completely. ( introduced a microporous design, minimizing streaming of the pores and reducing but not eliminating arterial wall damage. 29 Successful transfer of drugs, enzymes, and viral vectors using the passive diffusion technique has been reported with double-balloon systems.1013 However, a potential limitation of this device is a short interaction time, limited by distal ischemia induced by total arterial occlusion. The local delivery device used in this study provided prolonged interaction times between a highly concentrated drug and the injury site due to an autoperfusion system and caused no significant injury with the low-pressure and slightly oversized balloons matched for the size of the carotid artery. A recent study with a perfusion catheter with a similar flow rate showed that prolonged autoperfusion angioplasty can be performed in patients without clinical evidence of myocardial damage of hemolysis. 30 However, an important limitation of this device concerns vessels with significant side branches where appropriate seal with the double-balloon catheter may not be achieved.
Conclusions
Our findings in this short-term study indicate that local delivery of r-hirudin reduces quantitative platelet deposition and mural thrombus formation in the deeply injured porcine carotid artery after balloon angioplasty. The potential advantages of local r-hirudin were demonstrated at anticoagulant levels currently used in clinical trials. It remains to be determined whether there is a true advantage of local delivery of r-hirudin compared with higher doses of system therapy with r-hirudin. However, the risk of hemorrhage may be reduced by avoiding generalized impairment of hemostatic function after higher doses of systemic drug administration. The double-balloon autoperfusion catheter is a promising method for delivering high concentrations of drugs directly to the site of balloon injury for prolonged interaction times.
The present findings confirm that the specific thrombin inhibitor r-hirudin is a potent inhibitor of plateletmediated arterial thrombosis and suggest that its local delivery may be of value for the prevention of arterial thrombosis after balloon angioplasty.
